A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant
Clinical trial NCT00001439 · COMPLETED
Trial details
- NCT number
- NCT00001439
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1995-06-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.